Clinical bottom line
Goal-directed fluid therapy (GDFT) during major surgery offers a tailored approach to optimize perioperative hemodynamics, aiming to improve tissue perfusion and reduce complications. Recent high-quality evidence supports GDFT’s role in decreasing postoperative morbidity, including pulmonary complications and length of hospital stay, particularly in abdominal and oncologic surgeries. However, benefits may vary by surgical type and patient risk profile. Implementation requires appropriate monitoring technology and clinician expertise. While restrictive fluid strategies remain an alternative, GDFT provides individualized fluid management that may enhance outcomes when integrated into enhanced recovery protocols (Edwards et al., 2025; Jin et al., 2025).
What the evidence shows
Edwards et al. (2025) present a consensus statement from the Perioperative Quality Initiative endorsing GDFT as a key component of perioperative care, emphasizing individualized hemodynamic targets guided by dynamic monitoring to optimize stroke volume and cardiac output.
Jin et al. (2025) performed a systematic review and meta-analysis of intraoperative GDFT in oncologic surgeries, demonstrating significant reductions in postoperative complications, including infections and pulmonary events, as well as shorter hospital stays compared to standard fluid management.
Kutum et al. (2024) reviewed GDFT in neurosurgical patients, noting limited but promising data suggesting improved hemodynamic stability and potential reduction in cerebral edema, though evidence remains preliminary.
Huang et al. (2026) conducted a meta-analysis of non-drug perioperative interventions, including GDFT, showing decreased postoperative pulmonary complications after abdominal surgery, supporting GDFT’s role in multimodal strategies.
Older but relevant studies such as Bahlmann et al. (2019) provide foundational data on GDFT during major abdominal surgery, demonstrating improved hemodynamic parameters and reduced fluid overload.
Caveats and uncertainty
Heterogeneity in GDFT protocols, monitoring devices, and hemodynamic targets complicates direct comparisons across studies.
Evidence is strongest for abdominal and oncologic surgeries; data in neurosurgery and other specialties are less robust.
Implementation barriers include resource availability, training, and adherence to protocols.
Comparisons with restrictive or liberal fluid strategies yield mixed results; optimal fluid volumes remain debated.
Long-term outcomes and cost-effectiveness data are limited.
How this may change practice
Anesthesiologists should consider adopting GDFT protocols using validated dynamic monitoring tools in major abdominal and oncologic surgeries to reduce complications.
Integration of GDFT into enhanced recovery after surgery (ERAS) pathways may optimize perioperative care.
Education and training on GDFT principles and technology are essential for successful implementation.
Individualized fluid management should replace fixed-volume approaches, tailoring therapy to patient physiology.
Further research is warranted to refine protocols and expand evidence to other surgical populations.